Fluidigm is now Standard BioTools Inc.
Improving human health through innovative medicines is your mission.
Our mission is to provide you with the right, reliable products to solve your problems.
Introducing Standard BioTools™.
A company and a name that reflect our commitment to you, the researcher and inventor:
To unleash the power of essential, standardized tools that help the life science industry
develop breakthrough medicines faster and better.
Introducing the Hyperion+™ Imaging System
Advance efficiency with a simple stain-image-analyze workflow. Enable simultaneous phenotyping of 40-plus targets. Accelerate decisions from over 100 samples a week. A new standard for high-plex imaging.
Learn even more with expert input
on these powerful innovations.
Jul 03 - Jul 08
WCGALP (World Congress on Genetics Applied to Livestock Production) in Rotterdam, The Netherlands
Scientist in the Spotlight - H. Marks "Epigenetic mechanisms driving embryonic development"
Imaging Mass Cytometry™ Master Class: IMC Image Basics and Image Processing with MCD Viewer
Lindsy Rapkin, PhD
Jul 20 - Jul 22
FlowCytometry UK in Birmingham, UK
Sep 07 - Sep 09
SIGU (Italian Society of Human Genetics) National Congress in Trieste, Italy
Sep 16 - Sep 18
GLIIFCA XXXI (Great Lakes International Imaging and Flow Cytometry Association) in Indianapolis, IN
Sep 19 - Sep 22
CAR-TCR Summit in Boston, MA
Sep 19 - Sep 20
Forum LABO in Lyon, France
Sep 21 - Sep 22
International Spatial Biology Congress in The Hague, The Netherlands
Sep 21 - Sep 22
WACD 2022 (Western Association of Core Directors) at the California NanoSystems Institute at UC Los Angeles
Powerful. Intuitive. Transformative.
Empower the generation of meaningful answers to challenging questions, with proven microfluidics technology that can transform all PCR-based genomics studies. Imagine the possibilities, all on one platform.
1,000-PLUS Reasons to Trust Standard BioTools, formerly Fluidigm
Insights are all around us. Read our publications to see how we’re helping to bring validated scientific discovery to more people.VIEW ALL